{"transactions":[{"id":690776,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."}],"balance_after":0,"derivative":{"exercise_price":11.2,"exercise_date":"2024-05-23","expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690775,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."}],"balance_after":0,"derivative":{"exercise_price":19.36,"exercise_date":"2023-06-28","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690774,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":700,"price":111.41,"value":77987.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.15 to $111.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690773,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":110.64,"value":110640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.05 to $111.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690772,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":109.3,"value":196740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.89 to $109.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690771,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":108.38,"value":303464.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.84 to $108.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690770,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":1450,"price":107.58,"value":155991.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.79 to $107.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6300,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690769,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":11.2,"value":72800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."}],"balance_after":7750,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":690768,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T21:15:25.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":1250,"price":19.36,"value":24200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001779934-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000004/ownership.xml","form_type":"4"}},{"id":701482,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:54:49.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":41165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":332535,"source":{"system":"sec-edgar","filing":"0001079973-26-000991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000991/ownership.xml","form_type":"4"}},{"id":765982,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T20:30:09.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":6090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":6090,"derivative":{"exercise_price":89.63,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":6090},"source":{"system":"sec-edgar","filing":"0001779934-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000177993426000002/ownership.xml","form_type":"4"}},{"id":990204,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:26:26.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":40123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":". Represents restricted stock units that were fully vested upon grant."}],"balance_after":291370,"source":{"system":"sec-edgar","filing":"0001553350-25-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000148/ownership.xml","form_type":"4"}},{"id":990203,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:26:26.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":67901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":251247,"source":{"system":"sec-edgar","filing":"0001553350-25-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000148/ownership.xml","form_type":"4"}},{"id":1137208,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-22T20:41:53.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":18.36,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-076406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025076406/ownership.xml","form_type":"4"}},{"id":1352803,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-11-25T21:28:52.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":183346,"source":{"system":"sec-edgar","filing":"0001799191-24-000057","document":"wk-form4_1732570125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000057/wk-form4_1732570125.xml","form_type":"4"}},{"id":1500436,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T23:58:29.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":11000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000950170-24-065541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024065541/ownership.xml","form_type":"4"}},{"id":1698736,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-12-28T22:06:49.000Z","date":"2023-12-26","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":127346,"source":{"system":"sec-edgar","filing":"0001628280-23-042818","document":"wk-form4_1703801197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023042818/wk-form4_1703801197.xml","form_type":"4"}},{"id":1782078,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T01:14:00.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6500,"derivative":{"exercise_price":11.2,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0000899243-23-018863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924323018863/doc4.xml","form_type":"4"}},{"id":1943160,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-22T00:47:35.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":26247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date."}],"balance_after":71346,"source":{"system":"sec-edgar","filing":"0001628280-23-008828","document":"wf-form4_167944604001492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023008828/wf-form4_167944604001492.xml","form_type":"4"}},{"id":2108725,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T22:33:14.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":22708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date."}],"balance_after":45099,"source":{"system":"sec-edgar","filing":"0001799191-22-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000036/edgardoc.xml","form_type":"4"}},{"id":2218738,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-30T22:33:45.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 28, 2023 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":20000,"derivative":{"exercise_price":1.21,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-024669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924322024669/doc4.xml","form_type":"4"}},{"id":2300957,"issuer":{"id":128175,"kind":"organization","name":"SOC Telemed, Inc.","symbol":"TLMD"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Class A Common Stock","published_at":"2022-04-07T20:26:00.000Z","date":"2022-04-06","kind":"disposition_to_issuer","acquired":false,"shares":58387,"price":3,"value":175161.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 6, 2022, pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 2, 2022, by and among SOC Telemed, Inc. (the \"Issuer\"), Spark Parent, Inc. (\"Parent\") and Spark Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent, each share of the Issuer's Class A Common Stock (other than certain excluded shares) outstanding as of immediately prior to the effective time of the Merger (the \"Effective Time\") was canceled and automatically converted into the right to receive an amount in cash equal to $3.00 (the \"Merger Consideration\"), without any interest thereon and subject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-023675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779934/000120919122023675/doc4.xml","form_type":"4"}},{"id":2320120,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-23T23:34:04.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":6397,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22391,"source":{"system":"sec-edgar","filing":"0001628280-22-007093","document":"wf-form4_164807843000079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007093/wf-form4_164807843000079.xml","form_type":"4"}},{"id":2320119,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-23T23:34:04.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":15994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."}],"balance_after":15994,"source":{"system":"sec-edgar","filing":"0001628280-22-007093","document":"wf-form4_164807843000079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007093/wf-form4_164807843000079.xml","form_type":"4"}},{"id":2678718,"issuer":{"id":128175,"kind":"organization","name":"SOC Telemed, Inc.","symbol":"TLMD"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-07T21:07:39.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":21067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock.  The RSUs will vest in full on the first to occur of (x) the one-year anniversary of the grant date and (y) the date of the Issuer's next annual meeting of stockholders, subject to the continuous service of the Reporting Person as a member of the Issuer's Board of Directors through such vesting date."}],"balance_after":58387,"source":{"system":"sec-edgar","filing":"0001209191-21-038698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779934/000120919121038698/doc4.xml","form_type":"4"}},{"id":2683367,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T22:36:06.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":12.91,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-21-021849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321021849/doc4.xml","form_type":"4"}},{"id":2913230,"issuer":{"id":128175,"kind":"organization","name":"SOC Telemed, Inc.","symbol":"TLMD"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-01-07T18:36:44.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":37320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represents a contingent right to receive one share of the Issuer's Class A Common Stock, of which 1/3rd will vest on January 5 of each of 2022, 2023 and 2024, respectively, subject to the continuous service of the Reporting Person on each vesting date."}],"balance_after":37320,"source":{"system":"sec-edgar","filing":"0001209191-21-002458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1779934/000120919121002458/doc4.xml","form_type":"4"}},{"id":3116451,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:25:34.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 5, 2021 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":9.99,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-20-015797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320015797/doc4.xml","form_type":"4"}},{"id":3480149,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-24T21:04:19.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":36377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over three years, with 33% of this option vesting on June 20, 2020, and the remainder vesting in 24 equal monthly installments thereafter."}],"balance_after":36377,"derivative":{"exercise_price":14.94,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":36377},"source":{"system":"sec-edgar","filing":"0000899243-19-017955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924319017955/doc4.xml","form_type":"4"}}]}